IM this article to a friend!

September 14, 2004

Electrical and Magnetic Neurostimulation to Double by 2008

From: PR Newswire (press release) - Sep 14, 2004

NEW YORK, Sept. 14 /PRNewswire-FirstCall/ -- The $3.5 billion North American market for electrical and magnetic neurostimulation devices will more than double by 2008 to almost $7.7 billion, according to a new study released today from Kalorama Information. Some segments will show phenomenal growth, upwards of 50% annually.

The new study, "Electrical and Magnetic Nerve Stimulation: Applications, Technologies, and Market Potential," reveals that neurostrimulation, or neuromodulation, will continue to find applications across the therapeutic spectrum, from traditional markets such as electromuscular stimulation (EMS) and transcutaneous electrical nerve stimulation (TENS) for pain management to newer areas such as neuroprosthesis and functional electrostimulation (FES) for restoration of muscular or sensory function or techniques to treat depression and seizure disorders.

"Several high-profile systems are now passing through approval stages," notes James P. Smith, Ph.D., the principal author of the study, "and the potential of this market has clearly caught the eye of pharmaceutical and microelectronics companies, which are actively expanding their stake in electrode therapeutics through research, collaborations, and acquisitions."

"These actions will push more applications into the marketplace, and medical insurance will recognize a long-term savings for electronic treatment of chronic and debilitating conditions," predicts Dr. Smith. "Combined with new telemedicine strategies, implanted sensors, and drug delivery systems, electrical and magnetic neurostimulation can usher in a new wave of care for the chronically ill."

The study analyzes nine market segments in depth, including TENS, EMS, FES, sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), spinal cord stimulation (SCS), cochlear implants, and ocular implants. Research and business trends along with profiles of almost 50 competitors and a complete list of recent relevant patent filings.

This new report is priced at $3500 and is available for purchase at .

About Kalorama Information

Kalorama Information, an imprint of, supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or, or visit

About is the leading provider of global market intelligence products and services. With over 80,000 research publications from 350 research publishers, we offer instant online access to the world's most extensive database of expert insights on global industries. Updated daily. For more information, contact Matthew E. Seward at 301-468-3650 x205 or, or visit

SOURCE Kalorama Information
Web Site:

Copyright © 1996-2004 PR Newswire Association LLC. All Rights Reserved.